Correction to: Comparison of outcome after right colectomy with an enhanced recovery programme in patients with inflammatory bowel disease and patients operated on for other conditions: a monocentric retrospective study

Background. Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic relapsing disease indicated by inflammation of the gastrointestinal tract. Celiac disease (CeD) is a chronic autoimmune disease of the small bowel. The prevalence of CeD in IBD patients is unknown. Some studies have described the coexistence of the 2 diseases in the same patient. This study aimed to investigate the prevalence of CeD in Saudi Arabian children with IBD. Methods. We used a retrospective study design because data can be collected immediately and is easier to analyze afterward. The study was conducted on IBD patients in the Pediatric Gastroenterology Department at National Guard Hospital, Jeddah, Saudi Arabia. We enrolled Saudi patients aged between 1 and 18 years who had been diagnosed with IBD and CeD based on positive biochemical serology and histology from January 2011 to January 2020. We excluded patients with immunodeficiency disorders. Results. Among the 46 enrolled patients with IBD, CeD was identified in 4, and they did not develop any relapses. We discovered that the weight at IBD diagnosis improved significantly compared to current weight ( P-value < .0001). We also discovered that the height at diagnosis of IBD improved significantly compared to the current height ( P-value < .0001). Additionally, we found no significant associations between UC and CeD ( P-value = 1), or CD and CeD ( P-value = .625). Conclusion. No significant associations were evident between the prevalence of CeD and IBD. More prospective multicenter studies are needed to clarify the prevalence of CeD in children with IBD.

Download Full-text

Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study

International Journal of Colorectal Disease ◽

10.1007/s00384-020-03775-9 ◽

2020 ◽

Author(s):

Estefania Flores ◽

Chimezie Mbachi ◽

Ikechukwu Achebe ◽

Jennifer Asotibe ◽

Emmanuel Palomera-Tejeda ◽

...

Keyword(s):

Colorectal Cancer ◽

Inflammatory Bowel Disease ◽

Retrospective Study ◽

Bowel Disease ◽

Temporal Trend ◽

Inpatient Mortality ◽

Inflammatory Bowel

Download Full-text

Outcomes After Bowel Resection for Inflammatory Bowel Disease in the Era of Surgical Care Bundles and Enhanced Recovery

Journal of Gastrointestinal Surgery ◽

10.1007/s11605-019-04362-2 ◽

2019 ◽

Vol 24 (1) ◽

pp. 123-131 ◽

Cited By ~ 2

Author(s):

Anthony P. D’Andrea ◽

Prerna Khetan ◽

Reba Miller ◽

Patricia Sylla ◽

Celia M. Divino

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Bowel Resection ◽

Enhanced Recovery ◽

Surgical Care ◽

Care Bundles ◽

Inflammatory Bowel

Download Full-text

58 – Outcomes After Implementation of a Surgical Care Bundle for Colectomy Followed by Enhanced Recovery Protocol for Patients with Inflammatory Bowel Disease Undergoing Colorectal Resection

Gastroenterology ◽

10.1016/s0016-5085(19)40456-3 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-1373

Author(s):

Anthony D'Andrea ◽

Prerna Khetan ◽

Reba Miller ◽

Patricia Sylla ◽

Celia M. Divino

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Colorectal Resection ◽

Enhanced Recovery ◽

Surgical Care ◽

Care Bundle ◽

Enhanced Recovery Protocol ◽

Inflammatory Bowel

Download Full-text

SAT0249 IGA VASCULITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE. A RETROSPECTIVE STUDY

10.1136/annrheumdis-2019-eular.7413 ◽

2019 ◽

Author(s):

Michel Villatoro Villar ◽

Cynthia S. Crowson ◽

Ashima Makol ◽

Kenneth J. Warrington ◽

Steven R. Ytterberg ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Retrospective Study ◽

Bowel Disease ◽

Iga Vasculitis ◽

Inflammatory Bowel

Download Full-text

Do Patients With Inflammatory Bowel Disease Benefit from an Enhanced Recovery Pathway?

Inflammatory Bowel Diseases ◽

10.1093/ibd/izz172 ◽

2019 ◽

Vol 26 (3) ◽

pp. 476-483 ◽

Cited By ~ 4

Author(s):

David Liska ◽

Turgut Bora Cengiz ◽

Matteo Novello ◽

Alexandra Aiello ◽

Luca Stocchi ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Multivariate Analysis ◽

Bowel Disease ◽

Enhanced Recovery ◽

Hospital Costs ◽

Estimated Blood Loss ◽

Enhanced Recovery Pathways ◽

Inflammatory Bowel ◽

Outpatient Operations ◽

Recovery Pathways

Abstract Background Enhanced recovery pathways (ERPs) have been shown to reduce length of stay (LOS), complications, and costs after colorectal surgery; yet, little data exists regarding patients with inflammatory bowel disease (IBD). We hypothesized that implementation of ERP for IBD patients is associated with shorter LOS and improved economic outcomes. Methods An IRB-approved prospective clinical database was used to identify consecutive patients from 2015 to 2017. Patients were grouped as “pre-ERP” and “post-ERP” based on the date of implementation of a comprehensive ERP. Ileostomy closures, redo pouch operations, and outpatient operations were excluded. The relationship between ERP, LOS, and secondary outcomes was assessed using univariate and multivariate analysis. Results Overall, a total of 671 patients were included: 345 (51.4%) with Crohn’s disease (CD) and 326 (48.6%) with ulcerative colitis (UC). Of these, 425 were pre-ERP (63.4%), and 246 were post-ERP (36.6%). The groups did not differ in terms of age, gender, American Society of Anesthesiologist (ASA) scores, comorbidities, estimated blood loss, or ostomy construction. The post-ERP group had a significantly higher mean body mass index (BMI), more patients with CD, longer operative time, and more minimally invasive surgery (MIS; all P < 0.05). The post-ERP group had a significantly shorter LOS (6 vs 4.5 days, median), whereas mean hospital costs decreased by 15.7%. There was no difference in readmissions or complications. On multivariate analysis, MIS and ERP use were both associated with a shorter LOS. Conclusion Inflammatory bowel disease patients benefit from the use of ERP, demonstrating decreased LOS and costs without an increase in complications and readmissions. Enhanced recovery pathways should be routinely implemented in this often challenging patient population.

Download Full-text